1. DOP37 Efficacy and safety of filgotinib in patients with Ulcerative Colitis stratified by age: Post hoc analysis of the phase 2b/3 SELECTION and SELECTIONLTE studies. (21st January 2022) Authors: Schreiber, S; Loftus, E V; Maaser, C; Danese, S; Rudolph, C; Jongen, R; De Haas, A; Oortwijn, A; Vermeire, S Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i085 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Genetic variants in the autophagy pathway contribute to paediatric Crohn's disease. Issue 9 (21st August 2008) Authors: Peterson, N; Guthery, S; Denson, L; Lee, J; Saeed, S; Prahalad, S; Biank, V; Ehlert, R; Tomer, G; Grand, R; Rudolph, C; Kugathasan, S Journal: Gut Issue: Volume 57:Issue 9(2008) Page Start: 1336 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MEALS ON WHEELS: PERSPECTIVES FROM TODAY'S AGING ADULT. (16th November 2018) Authors: Rudolph, C; Francis, S Journal: Innovation in aging Issue: Volume 2(2018)Supplement 1 Page Start: 983 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP35 Efficacy and safety outcomes up to ~4 years of treatment with filgotinib 200 mg among patients with Ulcerative Colitis: Results from the SELECTIONLTE study. (30th January 2023) Authors: Feagan, B G; Matsuoka, K; Rogler, G; Faes, M; Oortwijn, A; de Haas, A; Rudolph, C; Peyrin-Biroulet, L Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P491 Efficacy and safety outcomes of long-term treatment with filgotinib 200 mg among patients with Ulcerative Colitis: An interim analysis of SELECTIONLTE. (21st January 2022) Authors: Feagan Senior Scientific Officer, B G; Matsuoka, K; Rogler, G; Faes, M; Oortwijn, A; de Haas, A; Rudolph, C; Patel, H; Peyrin-Biroulet, L Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P520 Thromboembolic and major adverse cardiovascular events among patients in the filgotinib clinical trial programme. (30th January 2023) Authors: van der Woude, J; Schreiber, S; Peyrin-Biroulet, L; Szekanecz, Z; Choy, E H; Stiers, P J; Van Hoek, P; Van Beneden, K; de Haas, A; Rudolph, C; ten Cate, H Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P624 Investigating the symptom burden among European patients with moderate-to-severe Crohn's disease using a real-world survey. (30th January 2023) Authors: Burisch, J; Hart, A; Sturm, A; Knight, H; Rudolph, C; Meadows, R; Oortwijn, A; Weatherby, S; Rolph, R; Dawod, F; Armuzzi, A Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i753 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗